Dr. Mehmet Fevzi Ozkaynak's Credentials

Accepting New Patients

Yes, this doctor is accepting new patients

Biography

Professor of Pediatrics Pediatric Hematology/Oncology, New York Medical College Director, Pediatric Blood and Marrow Transplant Program Maria Fareri Children’s Hospital at Westchester Medical Center EDUCATION: University of Hacettepe, School of Medicine, Ankara (1978) POSTGRADUATE EDUCATION AND TRAINING: Residency in Pediatrics, Hacettepe Children’s Hospital, Ankara (1978-1982) Residency in Pediatrics, Childrens Hospital of Los Angeles (1989-1991) Fellowship in Peds. Hem/Onc/BMT, Childrens Hospital of LA (1986-1989) ACADEMIC APPOINTMENTS: 2009-2010: Interim Chief, Peds Hem/Onc, NYMC, Dept. of Pediatrics 2003-Present: Professor of Pediatrics, New York Medical College 1999-2003: Associate Professor of Pediatrics, New York Medical College 1994-1999: Assistant Professor of Pediatrics, New York Medical College 1992-1994: Asst. Professor of Pediatrics, University of Southern California 1994-Present: Director, Peds. Blood & Bone Marrow Transplantation, Maria Fareri Children’s Hospital at Westchester Medical Center 1990-1993: Assistant Clinical Director, Autologous Bone Marrow Transplantation Program, Division of Hematology/Oncology, Childrens Hospital of Los Angeles 1993-1994: Director, Peripheral Stem Cell Program, Childrens Hospital of Los Angeles SELECTED ACTIVITIES: 1994-1999: Chairperson, Childrens Cancer Group Protocol #0935: A Phase I Study of Chimeric Human/Murine AntiGD2 Monoclonal Antibody (ch14.18) with GM-CSF in Children with Neuroblastoma. 1998-Present: Vice-Chairperson, Childrens Oncology Group #ANBL0032: Phase III Randomized Study of Chimeric Anti-GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue. 1997-2005: Chairperson, Childrens Oncology Group Protocol # AS973: A Randomized Comparison Between Antibiotics Alone and Antibiotics Plus G-CSF in Pediatric Patients with Chemotherapy Induced Febrile Neutropenia. 2000-2007: Chairperson, Pediatric Blood and Marrow Consortium, A Phase I Trial of Amifostine with L-PAM, Carboplatin, Etoposide with Escalating Doses of Cyclophosphamide with Autologous PBSC in Children with Pediatric Solid Tumors 2009-Present: Chairperson, Childrens Oncology Group #ANBL0931: A Comprehensive Safety Trial of Chimeric Antibody 14.18 (Ch14.18) with GM-CSF, IL-2 AND Isotretinoin in Hgh-Risk Neuroblastoma Patients Following Myeloablative Therapy. HOSPITAL AFFILIATIONS Childrens Hospital LA, LA, CA, Attending, 7/1991 – 6/1994 Maria Fareri Childrens Hospital/Westchester Medical Center, Valhalla, NY, Attending, 7/1994-Present Vassar Medical Center, Poughkeepsie, NY : Consultant, 2/1996-Present Danbury Hospital, Danbury, CT: Consultant, 7/1997-Present Our Lady of Mercy/Montefiore North, Bronx, NY: Consultant, 1/1999-Present

Languages

• English

Education

• Hacettepe Univ, Tip Fak, Hacettepe, Ankara, Turkey (Grad. 1978)

Other Specialties

• Oncologist / Hematologist

Areas of Expertise

• Blood and bone marrow donation
• Bone marrow biopsy and aspiration